, known internationally as the Johnson & Johnson vaccine.
The compound registered by pharmaceutical companies of the Johnson & Johnson group (the United States) and Janssen (Belgium) was thus authorized to be imported to Peru and used in the country.
For a year
"This type of health registry was created to allow experimental vaccines against the coronavirus SARS-CoV-2 to be used and imported to Peru," the health sector added.
Johnson & Johnson's compound is the fourth vaccine against COVID-19 authorized for use in Peru —after Sinopharm, Pfizer, and AstraZeneca.